tsourced software development for the worldwide market. Powered by our expert in-country linguistic resources, CSOFT delivers language translation/technology solutions into 90+ languages. CSOFT services a variety of industries such as information technology, manufacturing, life sciences, financial services, chemical and energy. Using industry best practices and processes, CSOFT streamlines translation and localization for software, product manuals, online help, marketing collaterals and website content, and offers multilingual publishing for virtually all formats.
About Beckman Coulter, Inc.
Beckman Coulter, Inc., based in Fullerton, California, is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum--from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing--Beckman Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around the world. For additional information, please visit www.beckmancoulter.com.
About Common Sense Advisory
Common Sense Advisory, Inc. is an independent research and analysis firm specializing in the on- and offline operations driving business globalization, internationalization, translation, and localization . Its research, consulting, and training help organizations improve the quality of global business. For more information about Common Sense Advisory's research, reports, and globalization and localization consulting services visit: http://www.commonsenseadvisory.com.
Founded in 1999, Lavasoft is "the original anti-spyware company", with over 350 million downloads worldwide fo
Page: 1 2 3 4 5 Related biology technology :1
Copyright©2009 Vocus, Inc.
All rights reserved
. Localization and Translation Leader CSOFT International Ltd. Recognizes Efforts of Two Key Members of its Business Development Team2
. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients3
. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 264
. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering5
. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.6
. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets7
. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results8
. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain9
. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter10
. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer11
. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line